4//SEC Filing
Caladrius Biosciences, Inc. 4
Accession 0001144204-17-001859
$LSTACIK 0000320017operating
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 5:48 PM ET
Size
9.4 KB
Accession
0001144204-17-001859
Insider Transaction Report
Form 4
Preti Robert A
See Remarks
Transactions
- Tax Payment
Common Stock
2017-01-09$3.54/sh−2,482$8,786→ 43,142 total - Award
Common Stock
2017-01-09+18,300→ 45,624 total - Award
Stock Option
2017-01-09+27,500→ 27,500 totalExercise: $3.54From: 2017-01-09Exp: 2027-01-09→ Common Stock (27,500 underlying)
Footnotes (3)
- [F1]Represents 18,300 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan. 25% of the shares of restricted stock vest immediately on the grant date and the remaining 75% of the shares of restricted stock will vest annually over the following three years.
- [F2]Includes 17,993 shares of unvested restricted stock.
- [F3]25% of the shares underlying the stock options vest immediately on the grant date and the remaining 75% of the shares underlying the stock options will vest annually over the following three years.
Documents
Issuer
Caladrius Biosciences, Inc.
CIK 0000320017
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000320017
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 5:48 PM ET
- Size
- 9.4 KB